Work

Minimal Residual Disease Status as a Surrogate Endpoint for Progression-free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis

Year: 2019

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2019.09.622

Authors: Hervé Avet-Loiseau, Heinz Ludwig, Ola Landgren, Bruno Paiva, Chris Morris, Hui Yang, Kefei Zhou, Sunhee Ro, Maria-Victoria Mateos

Institutions: Université de Toulouse, Wilhelminen Hospital, Memorial Sloan Kettering Cancer Center, Navarre Institute of Health Research, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, Amgen (United States), Instituto de Investigación Biomédica de Salamanca

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Amgen, Center for Outcomes Research and Evaluation, Yale School of Medicine, National Cancer Institute

Awards: G1829859322, Cancer Center Support Grant, Integrative Oncogenomics of Multiple Myeloma

OpenAlex ID: W2980015215

FWCI: 2.153

Cites: 57

Cited by: 133

Related to: 10